Modulation of matrix metalloproteinase (mmp) activity with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/56 (2006.01) A61K 31/585 (2006.01)

Patent

CA 2495376

The present invention is directed to a method for preventing an increase in matrix metalloproteinase (MMP) activity or reducing MMP activity in a subject in need thereof by administering to the subject a therapeutically effective amount of a selective aldosterone blocker. More particularly, the present invention is directed to attenuating or preventing an increase in MMP activity comprising administering eplerenone, or derivatives thereof.

L'invention concerne un procédé permettant d'empêcher une augmentation de l'activité de la métalloprotéinase matricielle (MMP) ou de réduire une telle activité chez un patient qui en a besoin par administration audit patient d'une dose thérapeutiquement efficace d'un anti-aldostérone sélectif. Plus précisément, l'invention concerne l'atténuation ou la prévention d'une augmentation de l'activité de MMP consistant à administrer l'éplérénone ou des dérivés de celui-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulation of matrix metalloproteinase (mmp) activity with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of matrix metalloproteinase (mmp) activity with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of matrix metalloproteinase (mmp) activity with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1686476

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.